| ★ | Novo CEO Sees 'Positive Growth on the Other Side of the Business' | Bloomberg Podcasts @bloombergpodcasts | 2.5K | Estados Unidos | |
| 1 | Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure | CNBC Television @cnbctelevision | — | Estados Unidos | 91 |
| 2 | Novo CEO Says Volumes to Compensate for Price Decreases | Bloomberg Television @markets | — | Estados Unidos | 91 |
| 4 | Novo Nordisk shares plummet as gloomy outlook shocks markets | | — | Estados Unidos | 90 |
| 5 | Generic Ozempic to Upend Global Weight-Loss Drug Market | Bloomberg News @bloomberg-news | — | Estados Unidos | 89 |
| 11 | AI Disruption Fears Spark Selloff; Novo Nordisk, AMD Drops After Earnings | Bloomberg Brief 2/4/2026 | Bloomberg Television @markets | — | Estados Unidos | 87 |
| 13 | Software Wipeout, Novo Sheds Market Share & UBS Wealth Outflows Weigh | The Opening Trade 2/4/2026 | Bloomberg Television @markets | — | Estados Unidos | 86 |
| 14 | What's Stopping GLP-1s From Getting Cheaper | | — | — | 86 |
| 15 | Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US | Bloomberg Television @markets | — | Estados Unidos | 86 |
| 16 | Novo Says It’s Suing Hims to Halt Obesity Drug Copycats | Bloomberg Podcasts @bloombergpodcasts | — | Estados Unidos | 86 |
| 17 | Alphabet Adds to the AI Debt Boom | Open Interest 2/9/2026 | Bloomberg Television @markets | — | Estados Unidos | 86 |
| 19 | Novo Says It’s Suing Hims; Lilly Strikes Deal for Biotech Orna; Alphabet Looks to Raise About... | Bloomberg Podcasts @bloombergpodcasts | — | Estados Unidos | 86 |
| 18 | Forget Injections. Now You Can Just Take Pills For Weight Loss | | 38.8K | — | 86 |
| 6 | The Fat Loss Miracle | The Honest Truth | | 27.6K | India | 89 |
| 7 | Why Eli Lilly is Winning the Weight Loss War | The Wall Street Journal @wsj | 27.4K | Estados Unidos | 88 |
| 3 | Novo Nordisk shares plunge after forecasting steep drop in sales #health | Bloomberg Television @markets | 8.1K | Estados Unidos | 90 |
| 20 | Down 66%, Is Novo Nordisk a Screaming Buy or a Value TRAP? (Full Analysis) | Brian Feroldi @brianferoldiyt | 7.7K | Estados Unidos | 86 |
| 9 | Weight Loss Wars Intensify as Novo sues to keep copycats off shelves | Bloomberg Television @markets | 4.2K | Estados Unidos | 87 |
| 12 | Down 66%, Is Novo Nordisk a Screaming Buy or a Value TRAP? (Full Analysis) 📱 | Brian Feroldi @brianferoldiyt | 3.4K | Estados Unidos | 87 |
| 8 | Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's rival pill | | 3.1K | Estados Unidos | 87 |
| 10 | Generic Ozempic will upend the global weight-loss drug market | Bloomberg Podcasts @bloombergpodcasts | 3.0K | Estados Unidos | 87 |